Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Page 43 - Sohini Das
PV dispatches highest ever in April, grow 13% YoY, shows SIAM data
2W dispatches up 15% YoY, auto body says all segments have posted growth this April, indicating smooth shift to BS VI Phase 2 emission norms
 "PV dispatches highest ever in April, grow 13% YoY, shows SIAM data")
Pricing regulator sets mechanism to fix prices of off-patent drugs
Prices to be capped at 50% of innovator price; to be reviewed after one year
 "Pricing regulator sets mechanism to fix prices of off-patent drugs")
Sanofi consumer brands get a shot in the arm on demerger decision
Demerging the pharma business will help the company focus on niche therapy areas, including bringing its global pipeline to India
 "Sanofi consumer brands get a shot in the arm on demerger decision")
Sanofi consumer brands get a shot in the arm on demerger decision
Sanofi Consumer Healthcare India is expected to be listed on both the BSE and NSE, the company said in an exchange notification
 "Sanofi consumer brands get a shot in the arm on demerger decision")
Dr Reddy's Laboratories Q4 PAT grows nine-fold riding on US, India biz
For the full year 2022-23, DRL's revenues were up 15 percent to Rs 24,587.9 crore while the PAT grew by 91 percent to Rs 4,506.7 crore
 "Dr Reddy's Laboratories Q4 PAT grows nine-fold riding on US, India biz")
Lupin reports 12% rise in Q4 sales riding on API, US and India biz
The revenue growth came from a strong API business performance along with US and domestic market sales growth
 "Lupin reports 12% rise in Q4 sales riding on API, US and India biz")
Govt, industry meet to focus on trade margin rationalisation of drugs
The Centre has been mulling on rationalizing drug trade margins for a while now for widely used medicines in an effort to bring down prices
 "Govt, industry meet to focus on trade margin rationalisation of drugs")
Drug sales stuck at pre-pandemic level, price rise shapes market growth
Respiratory medicines doing well as people recover from long-term effects of Covid-19
 "Drug sales stuck at pre-pandemic level, price rise shapes market growth")
Likely $10-billion injection: India's medtech a picture of health
Centre notifies the National Medical Devices Policy, 2023
 "Likely $10-billion injection: India's medtech a picture of health")
India's contribution to global clinical trials at 4% during 2010-22: Study
Top 20 pharma-sponsored trials in the country has increased by 10 per cent since 2013
 "India's contribution to global clinical trials at 4% during 2010-22: Study")
Luxury car maker Audi India starts production of Q3 SUV at Aurangabad plant
Audi was planning to make these cars in India along with the Audi Q5, A6, A4, Q7
 "Luxury car maker Audi India starts production of Q3 SUV at Aurangabad plant")
El Nino unlikely to dampen tractor industry volumes in a big way
Likely El Niño may water down sentiment but industry does not see huge downside in sales in FY24
 "El Nino unlikely to dampen tractor industry volumes in a big way")
Indo-French team designing novel molecule to slay Covid-19 infection
Covid-19 is a complex disease with short-term as well as long-term respiratory, inflammatory and neurological symptoms that are triggered by the infection by Sars-CoV-2 virus
 "Indo-French team designing novel molecule to slay Covid-19 infection")
Mahindra and Mahindra gears up for EV play, niche e-farm products
M&M aims to make 200,000 EVs a year around 2027
 "Mahindra and Mahindra gears up for EV play, niche e-farm products")
After a slow start, PLI scheme may switch on the afterburners in FY24
Rs 8,083 cr is expected to be disbursed this fiscal
 "After a slow start, PLI scheme may switch on the afterburners in FY24")
Import of key Chinese medical devices rises up to 152% till Dec FY23
Overall imports decline 8% in first nine months of FY23
 "Import of key Chinese medical devices rises up to 152% till Dec FY23")
Pharma firm Ipca Labs' plant gets 3 observations from US drugs regulator
The observations were followed by the USFDA inspection at the site from April 18 to April 26
 "Pharma firm Ipca Labs' plant gets 3 observations from US drugs regulator")
Govt approves National Medical Devices Policy 2023, eyes 12% market share
Mansukh Mandaviya, Union health minister, said that the policy has been designed keeping in mind the need to have a holistic policy framework and will accelerate the growth of this sector
 "Govt approves National Medical Devices Policy 2023, eyes 12% market share")
Abbott recalls a batch of thyroid disorder drug for labelling error
Thyronorm has no quality issue, mislabeled batch was invoiced in Madhya Pradesh and Telangana: Company
 "Abbott recalls a batch of thyroid disorder drug for labelling error")
Looking for long-term partner for EV biz: M&M exec director & CEO Jejurikar
"We do not need any funds; we are well-covered at the moment"
 "Looking for long-term partner for EV biz: M&M exec director & CEO Jejurikar")
